Search Results for "drug discovery"
Quantum Mechanics Bolsters Drug Discovery with QUELO-G and CUDA Graphs
Quantum mechanics is enhancing drug discovery through the use of QUELO-G and CUDA graphs.
AI-Driven Molecular De-Extinction: A New Frontier in Combating Drug-Resistant Pathogens
Researchers are using AI to resurrect DNA from extinct species to combat drug-resistant pathogens, potentially revolutionizing antibiotic discovery.
NVIDIA's NIM Agent Blueprint Transforms Drug Discovery with AI-Driven Virtual Screening
NVIDIA's NIM Agent Blueprint leverages generative AI for faster, cost-effective drug discovery, enhancing hit-to-lead transitions.
Montai Therapeutics Leverages NVIDIA NIM for Multimodal AI Drug Discovery
Montai Therapeutics collaborates with NVIDIA to develop a multimodal AI platform for drug discovery using NVIDIA NIM microservices.
Yale, Moderna, and NVIDIA Harness Quantum Computing for Drug Discovery
Yale, Moderna, and NVIDIA explore quantum machine learning to enhance drug discovery. The collaboration focuses on GPU-accelerated simulation of quantum algorithms for predicting molecular properties.
NVIDIA's GPU Innovations Revolutionize Drug Discovery Simulations
NVIDIA's latest GPU optimization techniques, including CUDA Graphs and C++ coroutines, promise to accelerate pharmaceutical research by enhancing molecular dynamics simulations.
AI-Driven Drug Discovery Revolutionizes Treatment Development
AI's integration into drug discovery is transforming the development of treatments, reducing time and cost significantly, according to NVIDIA's blog.
Mitsui & Co's Xeureka Utilizes NVIDIA AI for Secure Drug Discovery
Xeureka, a subsidiary of Mitsui & Co, leverages NVIDIA's AI platform to safely share healthcare data, enhancing drug discovery efforts through advanced confidential computing.
NVIDIA Introduces BioNeMo Blueprint to Revolutionize Protein Binder Design
NVIDIA unveils the BioNeMo Blueprint, a new AI-powered approach to accelerate protein binder design in drug discovery, leveraging GPU-accelerated microservices.
GenMol: A New Frontier in Molecular Generation for Drug Discovery
Explore GenMol, a generalist foundation model for molecular generation, and its advantages over SAFE-GPT in the realm of AI-driven drug discovery.
Protai Leverages NVIDIA NIM and AlphaFold for Enhanced Protein Structure Prediction
Protai advances drug discovery by integrating NVIDIA NIM with AlphaFold and proteomics, optimizing protein structure predictions for precision medicine.
AI and Organoids Revolutionize Brain Disease Research
BrainStorm Therapeutics leverages AI and organoids to advance drug discovery for brain diseases, aiming to reduce clinical trial failures and accelerate treatment development.